Old Web
English
Sign In
Acemap
>
authorDetail
>
Isabelle Ahrens-Fath
Isabelle Ahrens-Fath
Bayer Schering Pharma AG
Cancer research
Prostate
Carcinogenesis
Biology
Androgen receptor
5
Papers
151
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Activity results of the GATTO study, a phase Ib study combining the anti-TA-MUC1 antibody gatipotuzumab with the anti-EGFR tomuzotuximab or panitumumab in patients with refractory solid tumors.
2021
Journal of Clinical Oncology
Elena Garralda
Gianluca Del Conte
M. Macchini
Ignacio Matos
Konrad Klinghammer
Omar Saavedra Santa Gadea
Walter Fiedler
Christina C. Rolling
Maxim Kebenko
Francesco Raspagliesi
Domenica Larusso
Isabelle Ahrens-Fath
Beate Habel
Hans Baumeister
Alfredo Zurlo
Sebastian Ochsenreither
Show All
Source
Cite
Save
Citations (0)
Novel molecular aspects of prostate carcinogenesis
2008
Hellmuth-Alexander Meyer
Isabelle Ahrens-Fath
Anette Sommer
Bernard Haendler
Show All
Source
Cite
Save
Citations (7)
The fate of the duplicated androgen receptor in fishes: a late neofunctionalization event?
2008
BMC Evolutionary Biology
Veronique Douard
Frédéric Brunet
Bastien Boussau
Isabelle Ahrens-Fath
Virginie Vlaeminck-Guillem
Bernard Haendler
Vincent Laudet
Yann Guiguen
Show All
Source
Cite
Save
Citations (74)
Novel molecular aspects of prostate carcinogenesis.
2004
Biomedicine & Pharmacotherapy
Hellmuth-Alexander Meyer
Isabelle Ahrens-Fath
Anette Sommer
Bernard Haendler
Show All
Source
Cite
Save
Citations (12)
Androgen receptor function is modulated by the tissue-specific AR45 variant: Androgen receptor variant form
2004
FEBS Journal
Isabelle Ahrens-Fath
Oliver Politz
Christoph Geserick
Bernard Haendler
Show All
Source
Cite
Save
Citations (58)
1